| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/16/2006 | CA2570324A1 Rage fusion proteins and methods of use |
| 02/16/2006 | CA2569707A1 C-terminal modification of polypeptides |
| 02/15/2006 | EP1626096A2 In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/15/2006 | EP1626091A2 Duplexed parvovirus vectors |
| 02/15/2006 | EP1626090A1 Novel virus vector |
| 02/15/2006 | EP1626089A1 Lipid metabolic and signalling pathways in the epidermis |
| 02/15/2006 | EP1626088A1 Method of measuring glycolated hemoglobin a1c, enzyme to be used therefor and process for producing the same |
| 02/15/2006 | EP1626086A2 Double-stranded nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 02/15/2006 | EP1626085A1 Devices and methods for isolating RNA |
| 02/15/2006 | EP1626084A1 Compositions and methods for the diagnosis of tumours |
| 02/15/2006 | EP1626083A1 Substances for preventing and treating autoimmune diseases |
| 02/15/2006 | EP1626058A1 Compositions and methods for the diagnosis of tumour |
| 02/15/2006 | EP1626056A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity |
| 02/15/2006 | EP1626055A2 Non-mammalian GnRH analogs and uses thereof in the regulation of the immune system |
| 02/15/2006 | EP1625853A1 Apoptosis inducer for cancer cell |
| 02/15/2006 | EP1625852A1 Chimeric flavivirus vaccines |
| 02/15/2006 | EP1625796A1 Use of a high-ester pectin in acidic, protein-containing foodstuffs |
| 02/15/2006 | EP1625400A1 Method for selecting allosteric regulators of class iii g protein-coupled receptors |
| 02/15/2006 | EP1625395A1 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/15/2006 | EP1625378A2 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 02/15/2006 | EP1625230A2 Selection and evolution of chemical libraries |
| 02/15/2006 | EP1625229A1 Method and device for removal of organic molecules from biological mixtures |
| 02/15/2006 | EP1625223A2 Chemoenzymatic methods for the synthesis of statins and statin intermediates |
| 02/15/2006 | EP1625222A2 Broadening adenovirus tropism |
| 02/15/2006 | EP1625221A2 Method for the preparation of transgenic plants characterised by geminivirus lasting resistance |
| 02/15/2006 | EP1625220A2 An autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells |
| 02/15/2006 | EP1625219A1 Methods for producing secreted polypeptides |
| 02/15/2006 | EP1625216A2 Variant lipolytic enzymes |
| 02/15/2006 | EP1625214A1 New enterovirus, vaccines, medicaments and diagnostic kits |
| 02/15/2006 | EP1625210A2 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
| 02/15/2006 | EP1625208A2 Novel lipolytic enzyme lip2 |
| 02/15/2006 | EP1625206A2 siRNA INDUCED SYSTEMIC GENE SILENCING IN MAMMALIAN SYSTEMS |
| 02/15/2006 | EP1625205A2 Ancestral viruses and vaccines |
| 02/15/2006 | EP1625204A2 Genes encoding carotenoid compounds |
| 02/15/2006 | EP1625202A2 Novel lipolytic enzyme lip1 |
| 02/15/2006 | EP1625201A2 Production of carotenoids in microorganisms |
| 02/15/2006 | EP1625199A2 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 02/15/2006 | EP1625162A2 Compositions and methods for treatment of cryptococcosis |
| 02/15/2006 | EP1625157A2 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation |
| 02/15/2006 | EP1625149A2 Method and carrier complexes for delivering molecules to cells |
| 02/15/2006 | EP1625148A1 Peptide complex |
| 02/15/2006 | EP1625142A2 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 02/15/2006 | EP1625141A2 Grp94-based compositions and methods of use thereof |
| 02/15/2006 | EP1625138A2 Protected monomers |
| 02/15/2006 | EP1624899A2 Increased transduction using abc transporter substrates and/or inhibitors |
| 02/15/2006 | EP1624898A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/15/2006 | EP1624847A2 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 02/15/2006 | EP1624748A2 A transgenic animal model for cancer and stem cells |
| 02/15/2006 | EP1578802A4 Dna/rna transduction technology and its clinical and basic applications |
| 02/15/2006 | EP1527180A4 Homogentisate prenyl transferase ("hpt") nucleic acids and polypeptides, and uses thereof |
| 02/15/2006 | EP1511855A4 Expression profile of prostate cancer |
| 02/15/2006 | EP1481057B1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 02/15/2006 | EP1434873A4 Genotyping kit for diagnosis of human papilloma virus infection |
| 02/15/2006 | EP1421215A4 Methods for evaluating pathologic conditions using extracellular rna |
| 02/15/2006 | EP1334210B1 Genetic test for the identification of carriers of complex vertebral malformations in cattle |
| 02/15/2006 | EP1328652B1 Non-human transgenic animal expressing ca-ahr |
| 02/15/2006 | EP1226236B1 Polypeptides having glucanotransferase activity and nucleic acids encoding same |
| 02/15/2006 | EP1118664B1 Method for producing choroid plexus immortalized cell lines |
| 02/15/2006 | EP1095150B1 Formaldehyde dehydrogenase genes from methylotrophic yeasts |
| 02/15/2006 | EP1090129B1 Overexpression of phytase genes in yeast systems |
| 02/15/2006 | EP1080099B1 Method and device for purifying nucleic acids |
| 02/15/2006 | EP1065269B1 Genomic gene encoding hm1.24 antigen protein and promoter thereof |
| 02/15/2006 | EP0946741B1 Method for producing recombinant virus |
| 02/15/2006 | EP0871738B1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 02/15/2006 | EP0840794B1 Medicament containing at least one part of the ul84 protein of the cytomegalovirus, use of polypeptides corresponding to the amino acid sequence of the ul84 protein, and process for introducing ul84 into target cells |
| 02/15/2006 | EP0795021B1 Retroviral delivery of full length factor viii |
| 02/15/2006 | EP0791050B1 Vectors for tissue-specific replication |
| 02/15/2006 | EP0762892B1 Diphtheria toxin vaccines bearing a mutated r domain |
| 02/15/2006 | EP0754232B1 Plant lysophosphatidic acid acyltransferases |
| 02/15/2006 | CN1735694A Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 02/15/2006 | CN1735691A Fermentation process using specific oxygen uptake rates as a process control |
| 02/15/2006 | CN1735690A Thioesterase-related nucleic acid sequences and methods |
| 02/15/2006 | CN1735689A Bacterial virulence genes |
| 02/15/2006 | CN1735688A Compositions and methods for enhancing disease resistance in fish |
| 02/15/2006 | CN1735687A MK2 interacting proteins |
| 02/15/2006 | CN1735686A Method for producing ketocarotenoids by cultivating genetically modified organisms |
| 02/15/2006 | CN1735683A Methods and materials for the production of D-lactic acid in yeast |
| 02/15/2006 | CN1735630A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 02/15/2006 | CN1735629A Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
| 02/15/2006 | CN1735628A Polypeptides F' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 02/15/2006 | CN1735427A Pain relief agents |
| 02/15/2006 | CN1735338A Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
| 02/15/2006 | CN1733929A Recombinant human composite alpha interferon preparation method |
| 02/15/2006 | CN1733924A A method for regulating plant lignin content |
| 02/15/2006 | CN1733923A Method for regulating plant lignin content |
| 02/15/2006 | CN1733922A Super antigen fusion protein and its application method |
| 02/15/2006 | CN1733921A Nikkomycin biological synthesis regulating gene and its coded protein and engineering bacterium for expression |
| 02/15/2006 | CN1733920A Soybean disease-resistant gene and its coded protein and uses |
| 02/15/2006 | CN1733919A Transgenic method for promoting ratio value of soybean globin and conglycinin |
| 02/15/2006 | CN1733918A Motilin homologs |
| 02/15/2006 | CN1733917A Human phonosensitive nerve deafness related WFS1 mutant gene and its uses in diagnosing genetic deafness |
| 02/15/2006 | CN1733916A siRNA for suppressing Stat3 gene expression and its preparation method |
| 02/15/2006 | CN1733915A False gene data bank construction method of rice genome |
| 02/15/2006 | CN1733912A Gene recombinant fowl influenza virus D3/F-R2/6 and its construction method |
| 02/15/2006 | CN1733911A Recombinant virus containing BPI gene and pharmaceutical composition containing same and uses |
| 02/15/2006 | CN1733902A Transgenic bacillus strain secreting phytase and its uses |
| 02/15/2006 | CN1733807A Fusion protein possessing growth facilitation action and its coding gene and uses |
| 02/15/2006 | CN1733806A Polypeptide random library and its construction method, and method for screening polypeptide capable of penetrating cell from the library |
| 02/15/2006 | CN1733804A Single-chain antibody P1D3 counteracting prawn white spot syndrome virus and its preparation method |
| 02/15/2006 | CN1733802A Plant DREB transcription factor and its coding gene and uses |